These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

653 related items for PubMed ID: 24582749

  • 1. miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124.
    Gao Y, Fan X, Li W, Ping W, Deng Y, Fu X.
    Biochem Biophys Res Commun; 2014 Mar 28; 446(1):179-86. PubMed ID: 24582749
    [Abstract] [Full Text] [Related]

  • 2. Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation.
    Hu Y, Qin X, Yan D, Cao H, Zhou L, Fan F, Zang J, Ni J, Xu X, Sha H, Liu S, Yu S, Wu J, Ma R, Feng J.
    Tumour Biol; 2017 Mar 28; 39(3):1010428317691659. PubMed ID: 28345454
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA‑506‑3p reverses gefitinib resistance in non‑small cell lung cancer by targeting Yes‑associated protein 1.
    Zhu J, Tao L, Jin L.
    Mol Med Rep; 2019 Feb 28; 19(2):1331-1339. PubMed ID: 30535506
    [Abstract] [Full Text] [Related]

  • 4. MiR-181a contributes gefitinib resistance in non-small cell lung cancer cells by targeting GAS7.
    Ping W, Gao Y, Fan X, Li W, Deng Y, Fu X.
    Biochem Biophys Res Commun; 2018 Jan 22; 495(4):2482-2489. PubMed ID: 29269300
    [Abstract] [Full Text] [Related]

  • 5. Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer.
    Jang JY, Kim YG, Nam SJ, Keam B, Kim TM, Jeon YK, Kim CW.
    Mol Cancer Ther; 2016 Jun 22; 15(6):1387-96. PubMed ID: 26883272
    [Abstract] [Full Text] [Related]

  • 6. Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c.
    Narita M, Shimura E, Nagasawa A, Aiuchi T, Suda Y, Hamada Y, Ikegami D, Iwasawa C, Arakawa K, Igarashi K, Kuzumaki N, Yoshioka Y, Ochiya T, Takeshima H, Ushijima T, Narita M.
    PLoS One; 2017 Jun 22; 12(2):e0172115. PubMed ID: 28225782
    [Abstract] [Full Text] [Related]

  • 7. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway.
    Zhou J, Kwak KJ, Wu Z, Yang D, Li J, Chang M, Song Y, Zeng H, Lee LJ, Hu J, Bai C.
    Cell Physiol Biochem; 2018 Jun 22; 47(5):1909-1924. PubMed ID: 29961070
    [Abstract] [Full Text] [Related]

  • 8. Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer.
    Wang F, Meng F, Wong SCC, Cho WCS, Yang S, Chan LWC.
    Ther Adv Respir Dis; 2020 Jun 22; 14():1753466620915156. PubMed ID: 32552611
    [Abstract] [Full Text] [Related]

  • 9. Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p.
    Ma G, Zhu J, Liu F, Yang Y.
    DNA Cell Biol; 2019 Feb 22; 38(2):176-183. PubMed ID: 30601026
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines.
    Wang YS, Wang YH, Xia HP, Zhou SW, Schmid-Bindert G, Zhou CC.
    Asian Pac J Cancer Prev; 2012 Feb 22; 13(1):255-60. PubMed ID: 22502680
    [Abstract] [Full Text] [Related]

  • 11. MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
    Kitamura K, Seike M, Okano T, Matsuda K, Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K, Gemma A.
    Mol Cancer Ther; 2014 Feb 22; 13(2):444-53. PubMed ID: 24258346
    [Abstract] [Full Text] [Related]

  • 12. MiR-873 inhibition enhances gefitinib resistance in non-small cell lung cancer cells by targeting glioma-associated oncogene homolog 1.
    Jin S, He J, Li J, Guo R, Shu Y, Liu P.
    Thorac Cancer; 2018 Oct 22; 9(10):1262-1270. PubMed ID: 30126075
    [Abstract] [Full Text] [Related]

  • 13. miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer.
    Ge P, Cao L, Chen X, Jing R, Yue W.
    BMC Cancer; 2019 Dec 10; 19(1):1203. PubMed ID: 31823748
    [Abstract] [Full Text] [Related]

  • 14. MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer.
    Li B, Ren S, Li X, Wang Y, Garfield D, Zhou S, Chen X, Su C, Chen M, Kuang P, Gao G, He Y, Fan L, Fei K, Zhou C, Schmit-Bindert G.
    Lung Cancer; 2014 Feb 10; 83(2):146-53. PubMed ID: 24331411
    [Abstract] [Full Text] [Related]

  • 15. MiR-133a-3p attenuates resistance of non-small cell lung cancer cells to gefitinib by targeting SPAG5.
    Li Q, Wang Y, He J.
    J Clin Lab Anal; 2021 Jul 10; 35(7):e23853. PubMed ID: 34057242
    [Abstract] [Full Text] [Related]

  • 16. Reduced expression of EI24 confers resistance to gefitinib through IGF-1R signaling in PC9 NSCLC cells.
    Choi JM, Jang JY, Choi YR, Kim HR, Cho BC, Lee HW.
    Lung Cancer; 2015 Nov 10; 90(2):175-81. PubMed ID: 26342551
    [Abstract] [Full Text] [Related]

  • 17. miR-365a-5p suppresses gefitinib resistance in non-small-cell lung cancer through targeting PELI3.
    Li F, Li H, Li S, Lv B, Shi J, Yan H, Zhang H, He Y.
    Pharmacogenomics; 2020 Jul 10; 21(11):771-783. PubMed ID: 32635799
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer.
    Zhen Q, Liu J, Gao L, Liu J, Wang R, Chu W, Zhang Y, Tan G, Zhao X, Lv B.
    Cytogenet Genome Res; 2015 Jul 10; 146(1):1-8. PubMed ID: 26184032
    [Abstract] [Full Text] [Related]

  • 19. Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3.
    Yue J, Lv D, Wang C, Li L, Zhao Q, Chen H, Xu L.
    Oncogene; 2018 Aug 10; 37(31):4300-4312. PubMed ID: 29717264
    [Abstract] [Full Text] [Related]

  • 20. The long non-coding RNA SNHG5 regulates gefitinib resistance in lung adenocarcinoma cells by targetting miR-377/CASP1 axis.
    Wang Z, Pan L, Yu H, Wang Y.
    Biosci Rep; 2018 Aug 31; 38(4):. PubMed ID: 29592872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.